Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

ClinicalTrials.gov ID: NCT07195591

Public ClinicalTrials.gov record NCT07195591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Study of Resection and GammaTile® Followed by Concurrent External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant TMZ Versus Standard of Care in Newly Diagnosed Glioblastoma (GBM)

Study identification

NCT ID
NCT07195591
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
GT Medical Technologies, Inc.
Industry
Enrollment
766 participants

Conditions and interventions

Conditions

Interventions

  • External Beam Radiation Therapy Radiation
  • GammaTile® Device
  • Temozolomide Drug

Radiation · Device · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 9, 2025
Primary completion
Nov 30, 2031
Completion
Nov 30, 2031
Last update posted
Apr 29, 2026

2025 – 2031

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
HonorHealth Scottsdale Osborn Medical Center Scottsdale Arizona 85251 Recruiting
HMH Jersey Shore University Medical Center Neptune City New Jersey 07753 Recruiting
Westchester Medical Center Valhalla New York 10595 Recruiting
Brown University Health Providence Rhode Island 02903 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07195591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2026 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07195591 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →